An Individualized Approach to Biologic Therapy for Inflammatory Bowel Disease Using a Patient Online Decision Tool
Online CME Course
Course Description
The care of the patient with inflammatory bowel disease (IBD) is complex, with treatment options that may equally allow for differing treatment strategies. Understanding how patients with IBD assess the risks, benefits, quality of life, convenience, and cost trade-offs when they decide among the various biologic treatment options can help guide clinicians in clinical decision-making. This online CME module will be an interactive experience that will help physicians identify what matters most (i.e., mode of administration, effectiveness, etc.) to IBD patients when they decide among the different biologics.
Target Audience
This course is designed to meet the educational needs of primary care physicians and gastroenterologists.
Educational Objectives
- Optimize therapy for patients with IBD by learning about patient-reported experiences
- Summarize the side effects and concerns most commonly described by patients
- Describe which factors patients value most when making decisions about using biologic therapies for IBD
- Learn about the discrepancies between what physicians value when they prescribe biologics and what patients value with regards to biologic therapies
Accreditation Statement
Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Cedars-Sinai Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The California State Board of Registered Nursing accepts courses approved by the ACCME for Category 1 credit as meeting the educational requirements for license renewal.
Course Directors
Brennan M.R. Spiegel, MD, MSHS
Director, Health Services Research
Cedars-Sinai Medical Center
Christopher V. Almario, MD, MSHPM
Assistant Professor, Division of Digestive and Liver Diseases
Cedars-Sinai Medical Center
Planners
Michelle S. Keller, MPH
Research Scientist/Clinical Research Coordinator
Cedars-Sinai Medical Center
Garth Fuller, MS
Visiting Biostatistician
Cedars-Sinai Medical Center
Srinivas Gaddam, MD
Advanced Endoscopist, Division of Digestive and Liver Diseases
Cedars-Sinai Medical Center
Disclosure of Potential Conflicts of Interest
It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter’s content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations. While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice. In accordance with the policy of Cedars-Sinai, faculty are asked to disclose any affiliation or financial interest that may affect the content of their presentations.
Faculty, Planners, Reviewers Title/Affiliation/Disclosure
| Name of Individual | Individual’s Role in Activity | Name of Commercial Interest | Nature of Relationship |
|---|---|---|---|
| Brennan M.R. Spiegel, MD, MSHS | Course Director | My Total Health, GI Logic | Royalty |
| My Total Health, GI Logic | Receipt of Intellectual Property Rights/Patent Holder | ||
| Ironwood, Commonwealth, GI Health Foundation, Synergy Pharma, Allergan | Consulting Fee | ||
| Ironwood Pharmaceuticals, Nestle Health Science, AstraZeneca, Novartis Pharmaceuticals, Takeda Pharmaceuticals | Contracted Research | ||
| My Total Health | Ownership Interest | ||
| Christopher V. Almario, MD, MSHPM | Course Director | Gilead Sciences, Madrigal Pharmaceuticals | Ownership Interest |
| Michelle S. Keller, MPH | Planner | None | None |
| Garth Fuller, MS | Planner | None | None |
| Srinivas Gaddam, MD | Planner/Reviewer | None | None |
aa
Date of Release/Expiration
Release Date: June 30, 2017
Expiration Date: June 30, 2020
Estimated Time to Complete
1 hour
Acknowledgement of Commercial Support
Cedars-Sinai Medical Center gratefully acknowledges an educational grant in support of this educational activity from Takeda Pharmaceuticals U.S.A., Inc.
Method of Participation / How to Receive Credit
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Complete the CME/CE activity.
- Complete the online post-test. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
- Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
- Your CME/CE certificate will be available for download.
Contact Information
For technical issues, please direct inquiries to Dr. Christopher Almario, Cedars-Sinai Medical Center, at christopher.almario@csmc.edu. For CME credit issues, direct inquiries to the Office of CME, Cedars-Sinai Medical Center, at cme@cshs.org or (310) 423-5548.